Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice

Saut Horas H. Nababan, Cosmas Rinaldi Adithya Lesmana

Research output: Contribution to journalReview articlepeer-review

Abstract

Portal hypertension in nonalcoholic fatty liver disease (NAFLD) mostly occur in cirrhotic stage. However, several experimental and clinical studies showed evidence of portal hypertension in NAFLD without significant or advance fibrosis. This early development of portal hypertension in NAFLD is associated with liver sinusoidal contraction by hepatocellular lipid accumulation and ballooning, which is also accompanied by capillariza-tion and dysfunction of liver sinusoidal endothelial cells. Both of these impaired mechanical and molecular components can cause an increase in intrahepatic vascular resistance which lead to the increase of portal pressure in the absence of significant liver fibrosis. Extrahepatic factors such as insulin resistance and gut dysbiosis may also contribute to liver sinusoidal endothelial dysfunction and early portal hypertension in NAFLD. The clinical impact of early portal hypertension in NAFLD is still unclear. However, clinical tools for diagnosis and monitoring of portal hypertension in NAFLD are being investigated to predict high-risk patients and to guide therapy.

Original languageEnglish
Pages (from-to)979-985
Number of pages7
JournalJournal of Clinical and Translational Hepatology
Volume10
Issue number5
DOIs
Publication statusPublished - Oct 2022

Keywords

  • Metabolic
  • NAFLD
  • NASH
  • Portal hypertension

Fingerprint

Dive into the research topics of 'Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice'. Together they form a unique fingerprint.

Cite this